ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

INBS vs TNON // ALTMAN Z-SCORE & DEBT/EQUITY

Intelligent Bio Solutions Inc. (NASDAQ) VS. Tenon Medical Inc. (NASDAQ) • 15-METRIC TALLY: INBS 1 — TNON 4
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INBS VS. TNON) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC INBS TNON SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 40.80% 59.80% -19.00 TNON /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) -1.90% 20.40% -22.30 TNON /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity ACTIVE — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 5/9 -2.00 TNON /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 56.9 38.9 +18.00 INBS /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $6.1M $6.2M -$87.5K TNON /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR INBS REV TNON REV INBS GROSS % TNON GROSS % INBS FCF TNON FCF
FY 2025 $3.1M $3.9M 40.8% 59.8% -$9.9M -$11.0M
FY 2024 $3.1M $3.3M 45.8% 52.2% -$9.8M -$10.1M
FY 2023 $1.3M $2.9M — — -$7.4M -$12.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INBS // BETA —
TNON // BETA —